A liquid phase based C. elegans behavioral analysis system identifies motor activity loss in a nematode Parkinson's disease model

Journal of Neuroscience Methods

Volumn 204, Issue 2, 2012, Pages 234-237

  Zheng, Maohua ^a   Gorelenkova, Olga ^a   Yang, Jiong ^b   Feng, Zhaoyang ^a,b,c  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Case Western Reserve University   (United States)

^c XI'AN JIAOTONG UNIVERSITY   (China)

Author keywords

Behavioral analysis; C. elegans; Liquid phase; Parkinson's disease

Indexed keywords

LEUCINE RICH REPEAT KINASE 2;

ANIMAL MODEL; ARTICLE; BEHAVIORAL RESEARCH; CAENORHABDITIS ELEGANS; MOTOR ACTIVITY; NEMATODE; NERVE DEGENERATION; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; ANIMALS, GENETICALLY MODIFIED; ANTIPARKINSON AGENTS; AUTOMATIC DATA PROCESSING; CAENORHABDITIS ELEGANS; CAENORHABDITIS ELEGANS PROTEINS; GLUTAMIC ACID; HUMANS; LEVODOPA; MOTOR ACTIVITY; MUTATION; PARKINSON DISEASE; PROTEIN-SERINE-THREONINE KINASES; SERINE; SOFTWARE;

EID: 84855282470     PISSN: 01650270     EISSN: 1872678X     Source Type: Journal    
DOI: 10.1016/j.jneumeth.2011.11.015     Document Type: Article

References (32)

1. Brenner S. The genetics of Caenorhabditis elegans. Genetics 1974, 77:71-94.
2. Buckingham S.D., Sattelle D.B. Strategies for automated analysis of C. elegans locomotion. Invert Neurosci 2008, 8:121-131.
3. Buckingham S.D., Sattelle D.B. Fast, automated measurement of nematode swimming (thrashing) without morphometry. BMC Neurosci 2009, 10:84.
4. Cao P., Yuan Y., Pehek E.A., Moise A.R., Huang Y., Palczewski K., et al. Alpha-synuclein disrupted dopamine homeostasis leads to dopaminergic neuron degeneration in Caenorhabditis elegans. PLoS One 2010, 5:e9312.
5. de Bono M., Maricq A.V. Neuronal substrates of complex behaviors in C. elegans. Annu Rev Neurosci 2005, 28:451-501.
6. Doitsidou M., Flames N., Lee A.C., Boyanove A., Hobert O. Automated screening for mutants affecting dopaminergic-neuron specification in C. elegans. Nat Methods 2008, 5:869-872.
7. Faber P.W., Alter J.R., MacDonald M.E., Hart A.C. Polyglutamine-mediated dysfunction and apoptotic death of a Caenorhabditis elegans sensory neuron. Proc Natl Acad Sci USA 1999, 96:179-184.
8. Feng Z., Cronin C.J., Wittig J.H., Sternberg P.W., Schafer W.R. An imaging system for standardized quantitative analysis of C. elegans behavior. BMC Bioinformatics 2004, 5:115.
9. Feng Z., Li W., Ward A., Piggott B.J., Larkspur E.R., Sternberg P.W., et al. A C. elegans model of nicotine-dependent behavior: regulation by TRP-family channels. Cell 2006, 127:621-633.
10. Gehrke S., Imai Y., Sokol N., Lu B. Pathogenic LRRK2 negatively regulates microRNA-mediated translational repression. Nature 2010, 466:637-641.
11. Giacomotto J., Segalat L. High-throughput screening and small animal models, where are we?. Br J Pharmacol 2010, 160:204-216.
12. Hsu A.L., Feng Z., Hsieh M.Y., Xu X.Z. Identification by machine vision of the rate of motor activity decline as a lifespan predictor in C. elegans. Neurobiol Aging 2009, 30:1498-1503.
13. Kostrzewa R.M., Kostrzewa J.P., Brus R. Neuroprotective and neurotoxic roles of levodopa (l-DOPA) in neurodegenerative disorders relating to Parkinson's disease. Amino Acids 2002, 23:57-63.
14. Kraemer B.C., Zhang B., Leverenz J.B., Thomas J.H., Trojanowski J.Q., Schellenberg G.D. Neurodegeneration and defective neurotransmission in a Caenorhabditis elegans model of tauopathy. Proc Natl Acad Sci USA 2003, 100:9980-9985.
15. Kwok T.C., Ricker N., Fraser R., Chan A.W., Burns A., Stanley E.F., et al. A small-molecule screen in C. elegans yields a new calcium channel antagonist. Nature 2006, 441:91-95.
16. Lee B.D., Shin J.H., Vankampen J., Petrucelli L., West A.B., Ko H.S., et al. Inhibitors of leucine-rich repeat kinase-2 protect against models of Parkinson's disease. Nat Med 2010, 16:998-1000.
17. Link C.D. Expression of human beta-amyloid peptide in transgenic Caenorhabditis elegans. Proc Natl Acad Sci USA 1995, 92:9368-9372.
18. Luo L., Gabel C.V., Ha H.I., Zhang Y., Samuel A.D. Olfactory behavior of swimming C. elegans analyzed by measuring motile responses to temporal variations of odorants. J Neurophysiol 2008, 99:2617-2625.
19. Mayr L.M., Bojanic D. Novel trends in high-throughput screening. Curr Opin Pharmacol 2009, 9:580-588.
20. McGrath P.T., Rockman M.V., Zimmer M., Jang H., Macosko E.Z., Kruglyak L., et al. Quantitative mapping of a digenic behavioral trait implicates globin variation in C. elegans sensory behaviors. Neuron 2009, 61:692-699.
21. Paisan-Ruiz C., Jain S., Evans E.W., Gilks W.P., Simón J., van der Brug M. Cloning of the gene containing mutations that cause PARK8-linked Parkinson's disease. Neuron 2004, 44:595-600.
22. Pulak R. Techniques for analysis, sorting, and dispensing of C. elegans on the COPAS flow-sorting system. Methods Mol Biol 2006, 351:275-286.
23. Ramot D., Johnson B.E., Berry T.L., Carnell L., Goodman M.B. The Parallel Worm Tracker: a platform for measuring average speed and drug-induced paralysis in nematodes. PLoS One 2008, 3:e2208.
24. Stephens G.J., Johnson-Kerner B., Bialek W., Ryu W.S. Dimensionality and dynamics in the behavior of C. elegans. PLoS Comput Biol 2008, 4:e1000028.
25. Swierczek N.A., Giles A.C., Rankin C.H., Kerr R.A. High-throughput behavioral analysis in C. elegans. Nat Methods 2011, 8:592-598.
26. Tsechpenakis G., Bianchi L., Metaxas D., Driscoll M. A novel computational approach for simultaneous tracking and feature extraction of C. elegans populations in fluid environments. IEEE Trans Biomed Eng 2008, 55:1539-1549.
27. Voisine C., Varma H., Walker N., Bates E.A., Stockwell B.R., Hart A.C. Identification of potential therapeutic drugs for Huntington's disease using Caenorhabditis elegans. PLoS One 2007, 2:e504.
28. Yao C., El Khoury R., Wang W., Byrd T.A., Pehek E.A., Thacker C., et al. LRRK2-mediated neurodegeneration and dysfunction of dopaminergic neurons in a Caenorhabditis elegans model of Parkinson's disease. Neurobiol Dis 2010, 40:73-81.
29. Yuan Y., Cao P., Smith M.A., Kramp K., Huang Y., Hisamoto N., et al. Dysregulated LRRK2 signaling in response to endoplasmic reticulum stress leads to dopaminergic neuron degeneration in C. elegans. PLoS One 2011, 6:e22354.
30. Zhang S., Jin W., Huang Y., Su W., Yang J., Feng Z. Profiling a Caenorhabditis elegans behavioral parametric dataset with a supervised K-means clustering algorithm identifies genetic networks regulating locomotion. J Neurosci Methods 2011, 197:315-323.
31. Zigmond M.J., Hastings T.G., Abercrombie E.D. Neurochemical responses to 6-hydroxydopamine and l-dopa therapy: implications for Parkinson's disease. Ann NY Acad Sci 1992, 648:71-86.
32. Zimprich A., Biskup S., Leitner P., Lichtner P., Farrer M., Lincoln S. Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology. Neuron 2004, 44:601-607.